Incyte Corporation

Sherry Owens

Michael D Howell

Michael A Pratta

Beth Rumberger

Huiqing Liu

Biomarkers are provided that are associated with or predictive of a subject's responsiveness to a JAK inhibitor. The biomarkers, compositions, and methods described herein are useful in selecting appropriate treatment modalities for a subject having, suspected of having, or at risk of developing vitiligo.

Biomarkers for vitiligo

Biomarkers are provided that are predictive of a subject's responsiveness to a JAK inhibitor. The biomarkers, compositions, and methods described herein are useful in selecting appropriate treatment modalities for a subject having, suspected of having, or at risk of developing Graft-Versus-Host Disease.

Growing community of inventors

Wilmington, DE, United States of America

Sherry Owens